Vatelizumab

From Wikipedia, the free encyclopedia
Jump to: navigation, search
Vatelizumab
Monoclonal antibody
Type Whole antibody
Source Humanized
Target integrin alpha 2
Clinical data
ATC code
  • none
Identifiers
CAS Number
ChemSpider
  • none
 NYesY (what is this?)  (verify)

Vatelizumab is an immunomodulator. It binds to integrin alpha 2.[1]

References[edit]

  1. ^ World Health Organization (2011). "International Nonproprietary Names for Pharmaceutical Substances (INN). Proposed INN: List 105" (PDF). WHO Drug Information. 25 (2).